|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
Anxiety and Depression Conference in March
Anxiety and Depression Association of America
Attend the Anxiety and Depression Conference 2014, March 27-30, in Chicago. This is the best place to network, connect with others who have expertise in this area, discuss new research, generate referrals, and expand your network. Earn up to 30 CME or CE credits attending four days of educational sessions including Master Clinician workshops. This continuing education meeting does one of the best jobs translating research and presenting treatment and practice information focusing on children and adults.
ADAA Institute: Improv for Anxiety
March 27, 9 a.m. – 5 p.m.
Learn the fundamentals of improvisation and how to combine it with cognitive-behavioral therapy as a viable therapeutic tool for people with social anxiety disorder. Improv can also help clinicians think outside of the box, take risks, and become more comfortable with the uncertainties of nontraditional treatment methods. This may be the only workshop that requires you to be unprepared. Space is limited. Register now. http://www.adaa.org/resources-professionals/conference/institute-improv.
Cutting Edge Management of Anxiety and Depression
March 29, Chicago Marriott Downtown, Chicago, Illinois
This one-day program is specially designed to meet the continuing medical education needs of psychiatrists, nurse practitioners, psychiatric nurses and other mental health professionals focusing on the treatment of anxiety disorders and depression. Organized by the Anxiety and Depression Association of America in partnership with the Department of Psychiatry, Rush University Medical Center, this interactive session brings together nationally renowned experts and provides opportunities to discuss challenging cases and evidence-based treatments for children and adults. The program offers 8 AMA PRA Category 1 Credits™. There will be opportunities to speak with experts, discuss your practice challenges and network with peers. Read more here.
| Share this article:
Pharmacotherapy for anxiety disorders in children and teens
Anxiety and Depression Association of America- Wiley Health Learning
CME Webinar Jan. 29, 2-3 p.m. ET
Daniel S. Pine, M.D., National Institute of Mental Health
Anxiety disorders are the most common mental health disorders in children and teens, and most adults with anxiety disorders first developed their problem as children, so helping children with anxiety can alleviate acute suffering as well as have a long term impact on later risk for anxiety. This webinar will discuss data on the diagnosis of pediatric anxiety disorders, their categorization, long term outcome, and treatment. Available data will be reviewed from randomized controlled trials for pediatric anxiety, including both medications and psychotherapy, to provide insights for both practitioners and families from an evidence-base perspective.
Jan. 24, 2014, 12–1:30 p.m. ET
Transitioning to ICD-10: Why It's Important to Behavioral Health Care Providers and How To Prepare
The National Council for Behavioral Health will host this webinar. The 10th edition of the ICD (International Statistical Classification of Diseases and Related Health Problems) will modify diagnosis and inpatient procedure coding for everyone covered by the Health Insurance Portability and Accountability Act (HIPAA). All substance use or mental disorder services provided are subject to HIPAA standards. As a result, behavioral health providers must make this transition by Oct. 1, 2014.
https://www2.gotomeeting.com/register/436395306 to register.
New research in the treatment of social anxiety disorder
Stefan Hofmann, Ph.D., Boston University
Stefan Hofmann's recent research has uncovered a novel application of the drug d-cycloserine to treat social anxiety disorder. Listen to this podcast here .
RESEARCH AND PRACTICE NEWS
Primary care providers — initial treatment decisions and antidepressant prescribing for adolescent depression
Journal of Developmental and Behavioral Pediatrics
Adolescent depression is a serious and undertreated public health problem. Nonetheless, pediatric primary care providers may have low rates of antidepressant prescribing due to structural and training barriers. This study examined the impact of symptom severity and provider characteristics on initial depression treatment decisions in a setting with fewer structural barriers, an integrated behavioral health network.
Prolonged exposure vs supportive counseling for sexual abuse-related PTSD in adolescent girls: A randomized clinical
The Journal of the American Medical Association via PubMed
Evidence-based treatments for posttraumatic stress disorder (PTSD) have not been established for adolescents despite high prevalence of PTSD in this population. In this study, the goal was to examine the effects of counselor-delivered prolonged exposure therapy compared with supportive counseling for adolescents with PTSD.
A common brain pathway for anxiety and social behavior
Impaired social interaction is a common feature in autism, schizophrenia, depression, and anxiety, and it contributes to many of the problems that people with these conditions face. That is particularly true for adolescents with autism spectrum disorder, of whom about 40 percent are also diagnosed with anxiety. A new study from a laboratory at MIT found a circuit in the brain that might explain the link between impaired social interaction and anxiety in several disorders.
Meta-analytic findings of the relation between maternal prenatal stress and anxiety and child cognitive outcome
Journal of Developmental and Behavioral Pediatrics
Different studies have revealed mixed findings regarding the relation between maternal prenatal stress or anxiety (MPSA) and early child cognitive outcome. Different methodological considerations may be linked to the absence of clear support for this hypothesized link. The purpose of this article was to conduct a meta-analysis of this relation while considering the following as potential moderators: pregnancy trimester during which MPSA was assessed, type of MPSA assessment, and research design. Other moderators were also examined: child age at assessment and the year of publication.
Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: Systematic review and meta-analysis
British Medical Journal
The purpose of this study was to examine the risk for persistent pulmonary hypertension of the newborn associated with antenatal exposure to antidepressants. Of the 3077 abstracts reviewed, 738 papers were retrieved and seven included.
Depression: New causes, new treatments
People who experience depression are usually more focused on treating the condition than finding its cause. But new research is beginning to shed light on both the triggers for depression and how to alleviate it.
Depression affects one in ten Americans at some point in their lives, and the number of patients diagnosed with depression goes up by about 20 percent each year.
Teen concussions raise risk for depression
Teens with a history of concussion — the most common type of traumatic brain injury — are more than three times as likely to suffer from depression versus teens who have never had one, according to a new study published in the Journal of Adolescent Health.
Many teens experience concussions through sports injuries or accidents; however, most research on the psychological effects of concussions has focused on adults, and less is known about the long-term complications in young people.
Genetics may bring out the dark side of antidepressants
For years, it's been a controversial side effect of antidepressants: For all the patients helped by the drugs, there was a smaller cohort for whom the beginning of treatment triggered a descent into thoughts of suicide. Actual suicides are rare, but suicidal ideation can emerge in as many as one in twelve patients, most commonly in their first months on the drugs. Doctors can monitor for the side effects, but it's been a persistent danger, even as antidepressant use has skyrocketed.
Survey: ICD-10 preparedness lacking
By Pamela Lewis Dolan
As the deadline for switching to ICD-10 code sets inches closer, concern is growing that neither healthcare organizations nor insurers will be ready to go live by October. A survey by KPMG, a New York-based healthcare advisory firm, found the majority of health plans and providers have allocated budgets toward ICD-10 readiness and had completed impact assessments. But most had not yet conducted testing on their systems or determined how the conversion would impact revenue cycle and cash flow.
Antidepressants and suicide attempts among youth
New research suggests that all antidepressants are created more or less equal when it comes to their association with suicide attempts in children.
At least that’s the finding of a new population-based study from Vanderbilt University Medical Center in Nashville, Tenn.
William Cooper, M.D., and colleagues studied almost 37,000 kids and adolescents aged between 6 and 18 years who were new users of one of the following selective serotonin reuptake inhibitor or serotonin-norepinephrine reuptake inhibitor antidepressants: Fluoxetine, sertraline, paroxetine, citalopram, excitalopram and venlafaxine.
Recognition and treatment of social anxiety disorder
New guidance from NICE on social anxiety disorder aims to reduce delays in diagnosis and treatment, and to improve the quality of life of people with the disorder.
Social anxiety disorder is a common, debilitating and life-affecting disorder that is under-recognised and undertreated. Although many of us have experienced anxiety in social settings, such as at a job interview or at a party where we are not familiar with the other guests, people with SAD experience more intense and persistent emotions, fearing they will appear unacceptably foolish or awkward in the eyes of others.
Clinical experiences in conducting cognitive-behavioral therapy for social phobia
Behavior Therapy via ScienceDirect
Several authors have identified a disconnect between psychotherapy research, including research on cognitive behavioral therapy (CBT), and real-world psychotherapy practice. This disconnect has several negative consequences, potentially including less-than-optimal practice standards as well as a lack of input from practicing psychotherapists on how research can be improved and made more relevant in their day-to-day clinical work. As part of an ongoing effort to engage practicing psychotherapists in a feedback loop with psychotherapy researchers, this study reports the results of a survey of CBT therapists who have used CBT in the treatment of social phobia.
Study links anxiety to stroke occurrence
Prolonged elevated anxiety has been suggested by both scientists and clinicians to be a risk factor for stroke. Researchers from the University of Pittsburgh and Harvard School of Public Health conducted a study to confirm whether such an association does in fact exist.
In a given year, 6.8 million Americans suffer from anxiety symptoms, according to the National Institute of Mental Health.
Postpartum depression can turn chronic
Emerging research suggests that although the symptoms of postpartum depression decrease over time, a significant number of women develop chronic problems.
A recent report in the Harvard Review of Psychiatry suggests that postpartum depression remains a long-term problem for 30 to 50 percent of affected women.
Anxiety & Depression Insights
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit
Lauren Swan, Content Editor, 202.684.7496
Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.
This edition of Anxiety & Depression Insights was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063